作者: C Maenhoudt , NR Santos , E Fontaine , F Mir , K Reynaud
DOI: 10.1111/RDA.12041
关键词: Reproduction 、 Deslorelin 、 Internal medicine 、 Endocrinology 、 European union 、 Small animal 、 Agonist 、 Biology
摘要: Contents Over the last 10–15 years, long-acting GnRH agonists have become widely available. In field of small animal reproduction, most recent studies focused on use two compounds developed under form subcutaneous implants: azagly-nafarelin and deslorelin. Only latter has been commercially available for in male dogs, first Australia New Zealand, then several countries European Union since 2008. Although officially marketed this compound also studied bitches more recently queens. Some published papers or presentations at congresses – still unpublished implants females.